Globe Life (GL) AI Stock Analysis

• Market Cap: $11.16B
• Dividend Yield: 0.74%
• Average Volume (3M): 430.88K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.67
• Revenue Growth: 3.73%
• EPS Growth: 17.47%
• Country: US
• Employees: 3,732
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Life
• EPS (TTM): 4.81
• Shares Outstanding: 79,605,800
• 10 Day Avg. Volume: 491,554
• 30 Day Avg. Volume: 430,875
• PEG Ratio: 0.50
• Price to Book (P/B): 1.76
• Price to Sales (P/S): 1.62
• P/FCF Ratio: 7.03
• Enterprise Value/Market Cap: 1.22
• Enterprise Value/Revenue: 2.28
• Enterprise Value/Gross Profit: 6.76
• Enterprise Value/Ebitda: 8.70
• 1Y Price Target: $175.40
• Price Target Upside: 25.09% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: $152.00 ▲(8.40% Upside)

Overall score reflects solid financial performance and an attractive valuation (low P/E), supported by a generally positive earnings update with strong underwriting and earnings growth. This is tempered by mixed near-term technical signals and areas to watch in margins and free cash flow growth.

Positive Factors

High return on equity

A sustained ROE around 22% indicates Globe Life converts shareholder capital into profit efficiently. For an insurer, high ROE reflects profitable underwriting and investment returns, supporting book value growth and giving management flexibility to reinvest in distribution and reserves over the medium term.

Large exclusive agency force

A sizable, growing exclusive agent network is a durable competitive advantage in life insurance: it secures diversified distribution, improves customer acquisition and retention, and supports steady new business flows that underpin premium growth and margins across multiple years.

Rising underwriting margins

Material increases in underwriting margins signal durable improvements in pricing, product mix, or mortality experience. Higher underwriting margins enhance long-term earnings power for an insurance franchise and reduce sensitivity to investment income volatility when sustained by disciplined underwriting.

Negative Factors

Declining gross margin

A notable drop in gross margin suggests rising benefit costs, adverse product mix, or pricing pressure. For an insurer, persistent margin deterioration can erode underwriting profitability, require corrective pricing or reserve actions, and constrain the company’s ability to fund growth and capital returns over time.

Negative free cash flow growth

Declining free cash flow growth reduces internal funding for dividends, share repurchases, and new initiatives. Even with strong operating cash coverage, negative FCF growth signals potential emerging pressures on cash conversion or capital deployment, limiting financial flexibility in the medium term.

Direct-to-consumer premium weakness

Softness in the direct-to-consumer channel indicates vulnerability in a key acquisition pathway and less diversification of new business sources. If persistent, DTC weakness can slow scalable organic growth and increase reliance on agent recruiting or inorganic strategies to sustain premium expansion.

Globe Life Business Overview & Revenue Model

Company Description

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

How the Company Makes Money

Globe Life generates revenue primarily through the sale of life insurance policies and related products. The company earns premiums from policyholders, which constitute a significant portion of its revenue. In addition to premiums, Globe Life also earns investment income from the assets it holds, which include bonds and other investment vehicles. A key revenue stream comes from the renewal of existing policies, as many customers maintain their coverage over time. The company has established partnerships with various agents and brokers who help sell its products, contributing to its earnings. Additionally, Globe Life benefits from its efficient underwriting processes and a strong focus on customer retention, which enhances its profitability.

Globe Life Financial Statement Overview

Summary

Financials are solid overall: strong revenue growth and healthy profitability with strong ROE, supported by moderate leverage. Offsetting factors include a notable decline in gross margin and negative free cash flow growth, which warrant monitoring.

Income Statement

Globe Life shows a strong revenue growth trajectory with a TTM revenue growth rate of 97.9%, indicating robust expansion. However, the gross profit margin has decreased from 42.8% in 2024 to 34.4% in TTM, suggesting increased costs or pricing pressures. The net profit margin remains healthy at 19.4%, reflecting good profitability. EBIT and EBITDA margins are stable, indicating efficient operations.

Balance Sheet

The company's debt-to-equity ratio is stable around 0.51, indicating moderate leverage. Return on equity is strong at 22.1%, showcasing effective use of equity to generate profits. The equity ratio is not explicitly calculated, but the balance sheet reflects a solid equity base relative to assets, supporting financial stability.

Cash Flow

Operating cash flow is strong, with a coverage ratio of 3.05, indicating good cash generation relative to net income. However, free cash flow growth is negative at -7.6% TTM, which could signal potential cash flow challenges. The free cash flow to net income ratio is high at 95.1%, suggesting efficient conversion of income to cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.94B	5.78B	5.45B	5.23B	5.12B	4.74B
Gross Profit	2.01B	1.87B	1.64B	1.54B	1.69B	1.28B
EBITDA	1.56B	1.45B	1.30B	1.19B	1.36B	983.39M
Net Income	1.15B	1.07B	970.75M	894.39M	1.03B	731.77M
Balance Sheet
Total Assets	30.53B	29.08B	28.05B	25.99B	29.77B	29.05B
Cash, Cash Equivalents and Short-Term Investments	18.16B	17.41B	18.06B	16.71B	21.47B	21.42B
Total Debt	2.71B	2.74B	2.12B	2.08B	2.03B	1.92B
Total Liabilities	24.84B	23.77B	23.56B	22.04B	21.13B	20.28B
Stockholders Equity	5.69B	5.31B	4.49B	3.95B	8.64B	8.77B
Cash Flow
Free Cash Flow	1.25B	1.33B	1.43B	1.39B	1.40B	1.43B
Operating Cash Flow	1.38B	1.40B	1.48B	1.42B	1.44B	1.48B
Investing Cash Flow	-196.41M	-641.52M	-926.15M	-943.01M	-913.37M	-1.18B
Financing Cash Flow	-1.03B	-715.84M	-541.49M	-492.45M	-523.60M	-274.06M

Globe Life Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 140.22
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GL, the sentiment is Positive. The current price of 140.22 is above the 20-day moving average (MA) of 139.67, above the 50-day MA of 137.54, and above the 200-day MA of 131.76, indicating a bullish trend. The MACD of 0.08 indicates Positive momentum. The RSI at 53.95 is Neutral, neither overbought nor oversold. The STOCH value of 73.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GL.

Globe Life Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FG	77 Outperform	$3.97B	8.81	10.12%	2.91%	-4.58%	―
PRI	72 Outperform	$8.40B	12.07	33.91%	1.59%	5.63%	67.39%
JXN	72 Outperform	$8.08B	16.45	5.50%	2.98%	24.94%	―
LNC	71 Outperform	$7.90B	3.74	21.66%	3.93%	35.76%	636.97%
GL	70 Outperform	$11.16B	10.16	22.28%	0.74%	3.73%	17.47%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
UNM	64 Neutral	$12.71B	14.80	8.35%	2.22%	1.80%	-44.44%

Globe Life Corporate Events

Globe Life Amends Executive Retirement Plan

On November 5, 2025, Globe Life Inc. announced an amendment to its Supplemental Executive Retirement Plan (SERP). The amendment revises the early retirement reduction factor for benefits and provides conditions under which participants in the company’s Executive Severance Plan are deemed vested and eligible for retirement income during a change of control protection period.

The most recent analyst rating on (GL) stock is a Buy with a $148.00 price target. To see the full list of analyst forecasts on Globe Life stock, see the GL Stock Forecast page.